| Naziv: | A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor |
Autori: | Fallacara, Ana Lucia; Zamperini, Claudio; Podolski-Renić, Ana   ; Dinić, Jelena ; Stanković, Tijana; Nešović, Marija ; Mancini, Arianna; Rango, Enrico; Iovenitti, Giulia; Molinari, Alessio;
Bugli, Francesca; Sanguinetti, Maurizio; Torelli, Riccardo; Martini, Maurizio; Maccari, Laura; Valoti, Massimo; Dreassi, Elena; Botta, Maurizio; Pešić, Milica ; Schenone, Silvia;
|
Godina: | 2019 |
Publikacija: | Cancers |
ISSN: | 2072-6694 Cancers Pretraži identifikator |
Tip rezultata: | Naučni članak |
Kolacija: | vol. 11 br. 6 str. 848-848 |
DOI: | 10.3390/cancers11060848 |
WoS-ID: | 000475351200112 |
Scopus-ID: | 2-s2.0-85071177551 |
PMID: | 31248184 |
URI: | https://radar.ibiss.bg.ac.rs/handle/123456789/3379
https://enauka.gov.rs/handle/123456789/432620 |
URL: | https://www.mdpi.com/2072-6694/11/6/848 |
Projekat: | Identifikacija molekularnih markera za predikciju progresije tumora, odgovora na terapiju i ishoda bolesti (RS-41031)
COST Actions CM1106—Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells
COST Action CM1407—Challenging organic syntheses inspired by nature—from natural products chemistry to drug discovery
AIRC (Associazione Italiana per la Ricerca sul Cancro) Grant IG-2015, code 17677 |
M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
